Luokun Xie
Overview
Explore the profile of Luokun Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie L, Li W, Hersh J, Liu R, Yang S
J Cereb Blood Flow Metab
. 2018 Aug;
39(11):2268-2276.
PMID: 30092705
Mounting evidence has demonstrated that both innate and adaptive immune cells infiltrate into the brain after ischemic stroke. T cell invasion has been found in the ischemic region up to...
2.
Zhang H, Sun F, Wang J, Xie L, Yang C, Pan M, et al.
Aging Dis
. 2017 Apr;
8(2):203-214.
PMID: 28400986
Stroke survivors are typically left with structural brain damage and associated functional impairment in the chronic phase of injury, for which few therapeutic options exist. We reported previously that transplantation...
3.
Wang J, Xie L, Yang C, Ren C, Zhou K, Wang B, et al.
Front Cell Neurosci
. 2015 Oct;
9:361.
PMID: 26441532
Recent studies have demonstrated that the depletion of Regulatory T cells (Tregs) inhibits neural progenitor cell migration after brain ischemia. However, whether Tregs affect neural stem/progenitor cell proliferation is unclear....
4.
Xie L, Yang S
Brain Res
. 2015 Mar;
1623:63-73.
PMID: 25813828
The central nervous system (CNS) has long been recognized as a site of 'immune privilege' because of the existence of the blood brain barrier (BBB) which presumably isolates CNS from...
5.
Xie L, Choudhury G, Wang J, Park Y, Liu R, Yuan F, et al.
Front Cell Neurosci
. 2014 Oct;
8:315.
PMID: 25339866
Neural stem cell-based treatment holds a new therapeutic opportunity for neurodegenerative disorders. Here, we investigated the effect of methylene blue on proliferation and differentiation of rat neural progenitor cells (NPCs)...
6.
Xie L, Choudhury G, Winters A, Yang S, Jin K
Eur J Immunol
. 2014 Oct;
45(1):180-91.
PMID: 25329858
Forkhead box P3 (Foxp3)(+) regulatory T (Treg) cells maintain the immune tolerance and prevent inflammatory responses in the periphery. However, the presence of Treg cells in the CNS under steady...
7.
Xie L, Sun F, Wang J, Mao X, Xie L, Yang S, et al.
J Immunol
. 2014 May;
192(12):6009-19.
PMID: 24829408
Signaling by the mammalian target of rapamycin (mTOR) plays an important role in the modulation of both innate and adaptive immune responses. However, the role and underlying mechanism of mTOR...
8.
Poteet E, Winters A, Xie L, Ryou M, Liu R, Yang S
J Appl Toxicol
. 2013 Sep;
34(8):903-13.
PMID: 24037965
Cadmium is a toxic metal with no biological function in higher-order mammals. Humans are exposed to cadmium environmental contamination and the mechanism underlying the cadmium's cytotoxicity is unclear. To better...
9.
Ryou M, Choudhury G, Winters A, Xie L, Mallet R, Yang S
Brain Res
. 2013 Jul;
1530:66-75.
PMID: 23891792
Clinical application of recombinant tissue plasminogen activator (rtPA) for stroke is limited by hemorrhagic transformation, which narrows rtPA's therapeutic window. In addition, mounting evidence indicates that rtPA is potentially neurotoxic...
10.
Xie L, Li W, Winters A, Yuan F, Jin K, Yang S
Front Cell Neurosci
. 2013 May;
7:56.
PMID: 23653592
Methylene blue has been shown to be neuroprotective in multiple experimental neurodegenerative disease models. However, the mechanisms underlying the neuroprotective effects have not been fully elucidated. Previous studies have shown...